Glaxo Smithkline

[knightofdelta]

Originally Posted by horlads

No mind d guy...I can bet he's never bought Nestle into his personal portfolio before...See as d guy dey market NSE 30 like say na him be d chairman of d company...

NSE 30 na company? Abeg when was it listed?

I fear o. Me tink say na only me get access to my cscs account na

[horlads]

Originally Posted by knightofdelta

NSE 30 na company? Abeg when was it listed?

I fear o. Me tink say na only me get access to my cscs account na

Shuo...no be you dey define index investing a couple of days ago? Shebi na 'basket' of companies that is to say...a company of companies..

[Dicobody]

Originally Posted by Oracle

Did you buy this for dividends or capital appreciation? If you bought cos of the dividend(paltry 6% dividend yield assuming the price is N20 with dividend of N1.20),why didn't you go for Redstar even at N2.40 assuming the firm will repeat last year dividend of 30kobo. That will give you a yield of 12.5%. While you are getting dividend of 20,000* N1.20= N24,000 in GSK(before tax), you would have got 166,000*N0.30= N49,800 in Redstar(before tax) assuming you used the same fund for GSK above to buy Redstar at N2.4.
I'm not telling you to buy Redstar but i'm just giving you examples. And there are other examples there.

So one needs to understand why you bought.

Nice idea Oga Oracle.I bought b/c I want 2 make money tru both.I can't buy redstar 4 more than #2 if i to add more,cause they might partially disappoint with their dividend.though bought some at 1.95 some wks back.dividend expectation will drive redstar .'. good 4 cap. appreciatn.

[BigSeun]

2011 2010
N'000 N'000 %
Turnover 21,525.00 16,863.00 27.65%
Cost of Sales 12,537.00 9,420.00 33.09%
Gross Profit 8,988.00 7,443.00 20.76%
Operating Expenses 5,505.00 4,537.00 21.34%
Other Income 0.02 0.03 33.33%
Interest Charges 0.00 0.00 100.00%
Profit before tax 3,501.00 2,935.00 19.28%
Taxation 1,199.00 958.00 25.16%
Profit after tax 2,302.00 1,977.00 16.44%
EPS 2.41 2.07 16.43%

Balance Sheet
Fixed Assets 7,262.00 6,880.00 5.55%
Stocks 4,689.00 4,380.00 7.05%
Trade Debtors 936.00 1,065.00 12.11%
Cash & Bank Balances 3,983.00 1,127.00 253.42%
Other debit balances 1,067.00 800.00 33.38%
Trade Creditors 1,570.00 1,189.00 32.04%
Other creditors 7,364.00 5,217.00 41.15%
Working capital 3,510.00 2,229.00 57.47%
Net Assets 9,003.00 7,846.00 14.75%

Corporate Action
Dividend 120kobo per share
Closure Date 24th – 30th April 2012
AGM Date 22nd May 2012
Payment date 23rd May 2012

[blanka]

Originally Posted by BigSeun

2011 2010
N'000 N'000 %
Turnover 21,525.00 16,863.00 27.65%
Cost of Sales 12,537.00 9,420.00 33.09%
Gross Profit 8,988.00 7,443.00 20.76%
Operating Expenses 5,505.00 4,537.00 21.34%
Other Income 0.02 0.03 33.33%
Interest Charges 0.00 0.00 100.00%
Profit before tax 3,501.00 2,935.00 19.28%
Taxation 1,199.00 958.00 25.16%
Profit after tax 2,302.00 1,977.00 16.44%
EPS 2.41 2.07 16.43%

Balance Sheet
Fixed Assets 7,262.00 6,880.00 5.55%
Stocks 4,689.00 4,380.00 7.05%
Trade Debtors 936.00 1,065.00 12.11%
Cash & Bank Balances 3,983.00 1,127.00 253.42%
Other debit balances 1,067.00 800.00 33.38%
Trade Creditors 1,570.00 1,189.00 32.04%
Other creditors 7,364.00 5,217.00 41.15%
Working capital 3,510.00 2,229.00 57.47%
Net Assets 9,003.00 7,846.00 14.75%

Corporate Action
Dividend 120kobo per share
Closure Date 24th – 30th April 2012
AGM Date 22nd May 2012
Payment date 23rd May 2012

I'm looking at 2010 PAT and the 2010 annual report tells me Its N2.5B. But the numbers here says Its circa N2B. PAT actually dropped cos 2011 PAT is N2.3B. I think we should be careful about some of these numbers coming out of the NSE.

[Salida]

GlaxoSmithKline Consumer Nigeria Plc

May 15th, 2012

Unaudited Results (March, 2012, Q1)
Statement of Comprehensive Income
Revenue over 31/03/2012 N6.387b 31/03/2011 N4.962b Audited 11 N21.525b Cost of Sales 12 (N3.938b) 11 (N2.750b) Audited 11 (N12.537b)
Gross Profit 12 N2.448b 11 N2.212b Audited 11 N8.987b
Other Operating Income 12 N1.67m 11 N20.622m Audited 11 N23.304m
Selling, Distribution & Admin Expenses 12 (N1.656b) 11 (N1.322b) Audited 11 (N5.753b)
Finance Cost & Other Operating Expenses 12 (N34.411m) 11 (N34.033m) Audited 11 (N40.039m)
Profit before Tax 12 N784.661m 11 N883.653m Audited 11 N3.267b
Taxation 12 (N245.580m) 11 (N373.571m) Audited 11 (N1.192b)
Profit for the Year 12 N539.081m 11 N610.082m Audited 11 N2.076b
Other Comprehensive Income 12 N4.959m 11 Nil Audited 11 N19.835m
Total Comprehensive Income for the Period 12 N544.039m 11 N610.082m Audited 11 N2.096b
Earnings Per Share (kobo) 12 56 11 64 Audited 11 217

Statement of Financial Position
Plant, Property & Equipment 31-03-12 N7.316b 31-12-11 N7.276b
Inventories 12 N5.753b 11 N4.689b
Trade Receivables 12 N1.778b 11 N938.079m
Cash and Bank Balances 12 N4.510b 11 N3.983b
Other Debit Balances 12 N1.167b 11 N1.049b
Trade Payables 12 N1.739b 11 N1.570b
Short term Borrowings 12 Nil 11 Nil Other
Credit Balances 12 N2.559b 11 N7.411b
Working Capital 12 N3.637b 11 N3.133b
Net Assets 12 N9.496b 11 N8.952b

Corporate Actions

Proposed Dividend Nil

Proposed Bonus Nil

Qualification Date Nil

Closure Date Nil

AGM Date Nil

Payment Date Nil

AGM Venue Nil

[Salida]

Glaxosmithkline promise enhanced dividend, bonus shares

[Dicobody]

https://trwstockbrokers.files.wordpr...ne-nig-plc.pdf

[overload]

GLAXOSMITHKLINE CONSUMER NIGERIA PLC
August 1, 2012
HALF YEAR QUARTER Q2 RESULTS, JUNE, 2012
Statement of Comprehensive Income
Turnover 30/06/2012 N12.846b 30/06/2011 N10.184b Audited 31-12-11 N21.525b
Cost of Sales 12 (N7.764b) 11 (N5.866b) Audited 11 (N12.538b)
Gross Profit 12 N5.082b 11 N4.319b Audited 11 N8.988b
Other Income 12 N5.097m 11 N32.357m Audited 11 N23.304m
Marketing, Distribution & Admin Expenses 12 (N3.243b) 11 (N2.719b) Audited 11 (N5.566b)
Interest & Similar Charges 12 (N92,000) 11 (N469,000) Audited 11 (N1.787m)
Finance Income 12 N91.888m 11 N17.188m Audited 11 N49.666m
Profit before Tax 12 N1.936b 11 N1.649b Audited 11 N3.493b
Taxation 12 (N621.266m) 11 (N506.955m) Audited 11 (N1.198b)
Profit after Tax 12 N1.314b 11 N1.142b Audited 11 N2.295b
Other Comprehensive Income 12 Nil 11 Nil Audited 11 N19.835m
Total comprehensive Income 12 N1.314b 11 N1.142b Audited 11 N2.315b
Basic Earnings Per Share (k) 12 137k 11 119k Audited 11 240k

Statement of Financial Position
Property, Plant & Equipment 30-06-12 N7.432b 31-12-11 N7.282b
Inventories 12 N6.416b 11 N4.689b
Trade & Other Receivables 12 N3.453b 11 N1.985b
Cash and Cash Equivalents 12 N4.332b 11 N3.984b
Trade & Other Payables 12 N9.667b 11 N6.718b
Current Tax Payable 12 N1.429b 11 N852.768m
Deferred Tax Liabilities 12 N1.273b 11 N1.276b
Other Provisions 12 N114.224m 11 N111.065m
Working Capital 12 N3.104b 11 N3.087b
Net Assets 12 N9.149b 11 N8.982b

[Dicobody]

http://www.nse.com.ng/Financial%20Ne...BER%202012.PDF

[Salida]

GlaxoSmithKline introduces Physiogel range into the Nigerian market

[hispy99]

Africa Industrialisation Day and GSK’s Expansion Effort, Articles | THISDAY LIVE

[hispy99]

GSK to spend $1bn to lift stakes in Nigeria, India units

[manemi]

Originally Posted by hispy99

GSK to spend $1bn to lift stakes in Nigeria, India units

The parent company is actually investing the money by buying up shares to increase its stake from 46% to 80%. They are just going to take away more profits from Nigeria, while not investing to expand operations of the company. As a Nigerian investor I think this is not positive.

[goldsun]

Originally Posted by manemi

The parent company is actually investing the money by buying up shares to increase its stake from 46% to 80%. They are just going to take away more profits from Nigeria, while not investing to expand operations of the company. As a Nigerian investor I think this is not positive.

i think people will be targeting the premium they'll get from the takeover

[manemi]

Originally Posted by goldsun

i think people will be targeting the premium they'll get from the takeover

That is being short sighted. These actions are eroding the depth of the NSE. Remember NBC? Very soon Dangote Flour will disappear.

[emmanuel ewumi]

Originally Posted by manemi

The parent company is actually investing the money by buying up shares to increase its stake from 46% to 80%. They are just going to take away more profits from Nigeria, while not investing to expand operations of the company. As a Nigerian investor I think this is not positive.

Can't they have a right issue, so that interested shareholders can invest more funds in the company.

I won't be surprised if this company is delisted in the next 5 years.

[emmanuel ewumi]

Originally Posted by goldsun

i think people will be targeting the premium they'll get from the takeover

Is this in the long term benefit of the Nigerian investor?

[goldsun]

Originally Posted by emmanuel ewumi

Is this in the long term benefit of the Nigerian investor?

and who has ever consider the nigerian investor while making his decision

[emmanuel ewumi]

Originally Posted by goldsun

and who has ever consider the nigerian investor while making his decision

Nobody, but the Nigerian investors. if Nigerian investors will stand up and fight, you will find out that the plan will not materialise.